Jazz Pharma Plc (JAZZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Sales | 173,781 | 128,449 | 67,514 | 65,303 | 44,856 |
| Cost of Goods | 13,559 | 9,638 | 13,924 | 8,903 | 6,968 |
| Gross Profit | 160,222 | 118,811 | 53,590 | 56,400 | 37,888 |
| Operating Expenses | 102,992 | 103,519 | 224,879 | 196,081 | 116,908 |
| Operating Income | 57,789 | 15,930 | -170,365 | -138,778 | -78,052 |
| Interest Expense | 12,724 | 22,796 | 19,742 | 13,647 | 14,129 |
| Other Income | -12,287 | 30 | 5,768 | 13,599 | 32,790 |
| Pre-tax Income | 32,778 | -6,836 | -184,339 | -138,826 | -59,391 |
| Net Income Continuous | 32,778 | -6,836 | -184,339 | -138,826 | -59,391 |
| Net Income | $32,778 | $-6,836 | $-184,339 | $-138,826 | $-59,391 |
| EPS Basic Total Ops | 0.90 | -0.23 | -7.19 | -10.04 | -6,254.69 |
| EPS Basic Continuous Ops | 0.90 | -0.23 | -7.19 | -10.04 | -4,568.54 |
| EPS Diluted Total Ops | 0.83 | -0.23 | -7.19 | -10.04 | -6,254.69 |
| EPS Diluted Continuous Ops | 0.83 | -0.23 | -7.19 | -10.04 | -4,568.54 |
| EBITDA(a) | $66,500 | $25,027 | $-155,339 | $-128,252 | $-67,742 |